Literature DB >> 4722459

Inhibition of binding of aldehydes of biogenic amines in tissues.

F Ungar, B Tabakoff, S G Alivisatos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4722459     DOI： 10.1016/0006-2952(73)90050-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

2.  Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.

Authors:  Lydia M M Vermeer; Virginia R Florang; Jonathan A Doorn
Journal:  Brain Res       Date:  2012-07-31       Impact factor: 3.252

3.  Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde.

Authors:  Brigitte C Vanle; Virginia R Florang; Daryl J Murry; Arturo L Aguirre; Jonathan A Doorn
Journal:  Biochem Biophys Res Commun       Date:  2017-08-19       Impact factor: 3.575

4.  Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease.

Authors:  Yunden Jinsmaa; Virginia R Florang; Jennifer N Rees; Lydia M Mexas; Laurie L Eckert; Erin M G Allen; David G Anderson; Jonathan A Doorn
Journal:  Chem Biol Interact       Date:  2011-01-13       Impact factor: 5.192

5.  Real-time monitoring of tyrosine hydroxylase activity using a plate reader assay.

Authors:  Lydia M Vermeer; Colin A Higgins; David L Roman; Jonathan A Doorn
Journal:  Anal Biochem       Date:  2012-09-23       Impact factor: 3.365

6.  Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.

Authors:  Yunden Jinsmaa; Virginia R Florang; Jennifer N Rees; David G Anderson; Stefan Strack; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

7.  Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol.

Authors:  Jennifer N Rees; Virginia R Florang; Laurie L Eckert; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

8.  Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite.

Authors:  David G Anderson; Virginia R Florang; Josephine H Schamp; Garry R Buettner; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2016-06-15       Impact factor: 3.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.